CANDEL THERAPEUTICS I
5.0900
07-November-24 14:59:58
15 minutes delayed
Stocks
-0.2400
-4.50%
Today's range
5.0700 - 5.3600
ISIN
N/A
Source
NASDAQ
-
30 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day
01 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Participate in Upcoming B. Riley Oncology Conference
12 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 15:26:35 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Host Virtual R&D Day on December 6, 2022
29 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10 Nov 2022 07:00:03 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO
07 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation for November
01 Nov 2022 07:00:03 By Nasdaq GlobeNewswire
-
15 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Announces Two Executive Leadership Appointments
07 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Upcoming Investor Conference Participation
06 Sep 2022 07:00:02 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
05 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Candel Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
18 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
12 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
27 Apr 2022 15:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 07:00:01 By Nasdaq GlobeNewswire